Page 62
Participants taking tirzepatide lost up to 52 lb. (24 kg) in this 72-week phase 3 study 63% of participants taking tirzepatide 15 mg achieved at least 20% body…
Mater Private Network, in partnership with Boston Scientific, has announced today that it is the first hospital network in Ireland and within only 25 centres in the world…
Údarás na hOllscoile, the Governing Authority of NUI Galway, has today approved the renaming of the institution to Ollscoil na Gaillimhe – University of Galway. The University is…
Researchers point to groundbreaking potential to screen for those at high risk of disease and for clinical trials of new treatments New research from NUI Galway and Boston…
With Organ Donor Awareness Week just around the corner (Saturday 23rd– Saturday 30th April) the announcement from the Mater Hospital and St. Vincent University Hospital today about Polish…
RCSI 2022 Charter Meeting to look across the career span of a surgeon Honorary Fellowship to be awarded to Roddy Doyle The 2022 Charter Meeting takes place today…
Teams from the Mater Hospital and St Vincent’s collaborated on this rare double transplant Martin Malinowski from Co. Monaghan is the first person in Ireland to receive a…
NUI Galway scientists show that smaller scorpion species pack the most potent venoms Researchers in NUI Galway have shown, for the first time, that smaller species of scorpions,…
Commenting on the South Kerry CAMHS Review and Compensation Scheme, the President of the IHCA, Professor Alan Irvine said: “The consequences of the resourcing crisis in our health…
Pfizer Ireland marked the approval for VYNDAQEL ® (tafamidis). A once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin amyloidosis. This is in adult…
You’re all caught up.
